Researchers conduct the most extensive analysis on the genomic, epigenomic, and transcriptomic changes in Alzheimer’s patient brains. By analyzing over 2 million cells from 400 postmortem samples, they've uncovered a detailed picture of the disease's genetic and molecular foundation.